NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.680
+0.150 (5.93%)
Aug 14, 2025, 11:39 AM - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $52.27 million as of August 14, 2025. Its market cap has increased by 106.51% in one year.
Market Cap
52.27M
Enterprise Value
52.19M
1-Year Change
106.51%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since December 4, 2017, NRx Pharmaceuticals's market cap has decreased from $82.80M to $52.27M, a decrease of -36.87%. That is a compound annual growth rate of -5.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 49.34M | 85.97% |
| Dec 31, 2024 | 26.53M | -30.71% |
| Dec 29, 2023 | 38.30M | -48.99% |
| Dec 30, 2022 | 75.08M | -73.29% |
| Dec 31, 2021 | 281.11M | 328.57% |
| Dec 31, 2020 | 65.59M | 1.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |